AzTrials
AzTrials

Hip FracturesPhase 4NCT02255591

Shamrock Versus Lumbar Ultrasound Trident - Ultrasound Guided Block of the Lumbar Plexus

A Phase 4 study testing Lidocaine-adrenaline added gadolinium. in people with Hip Fractures and Anesthesia Local, run by University of Aarhus at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of the trial is to complete a double-blinded randomized controlled trial of a lumbar plexus block with the Shamrock technique versus the Lumbar Ultrasound Trident technique by estimating the time of performance of lumbar plexus blocks in healthy volunteers. Read more about this study

Who is it for?
Ages 18 to 65 years, men onlyHealthy volunteers can take part
What is being tested?
Lidocaine-adrenaline added gadolinium.
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteDenmark
Study dates
Feb 2015to Mar 2015
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male
  • Age ≥ 18 years
  • Volunteers who have given their written and oral consent to participate in the study after fully understanding the content and the limitations of the protocol
  • Normal healthy volunteer (American Society of Anesthesiology (ASA) Classification I)

Who cannot join

  • Volunteers not able to cooperate for the study
  • Volunteers not able to understand Danish
  • Daily use of analgesics
  • Allergy against the medicines used in the study
  • Drug abuse (according to the investigator's judgement)
  • Alcohol consumption larger than the recommendations of the Danish National Board of Health
Show all 9Show fewer
  • Volunteers in whom nerve blocks are not possible due to technical reasons
  • Volunteers who meet any contraindication for MRI including claustrophobia
  • Volunteers who are incompetent, i.e. surrogate consent is not accepted

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Department of Aneshtesiology and Intensive Care Medicine; Aarhus University Hospital

    Aarhus C, DK-8000

Other trials in Denmark

About this study

Official title: Shamrock Versus Lumbar Ultrasound Trident - Ultrasound Guided Block of the Lumbar Plexus: A Randomized Controlled Trial

The main objective of the trial is to complete a double-blinded randomized controlled trial of a lumbar plexus block with the Shamrock technique versus the Lumbar Ultrasound Trident technique by estimating the time of performance of lumbar plexus blocks in healthy volunteers.

Secondary objectives include a) estimates of number and depth of needle injections, distance of injection site from the midline, minimal electric nerve stimulation to trigger muscular response and the type of response, and volunteer discomfort during block injection, b) measurements of plasma lidocaine and mean arterial blood pressure, c) examinations of sensory block of the dermatomes T8-S3 and motor block of the femoral nerve, the obturator nerve, the hip abductor muscles, and the hamstring muscles, d) success rate of lumbar plexus block, e) perineural and epidural distribution of local anesthetics added contrast visualized on magnetic resonance imaging (MRI) scanning, and f) cost-effectiveness for the Shamrock technique versus the Lumbar Ultrasound Trident Technique for lumbar plexus block in healthy volunteers.

The hypothesis is that the Shamrock technique is faster to perform than the Lumbar Ultrasound technique, and that the success rate of the Shamrock technique is equal to or higher than the Lumbar Ultrasound Trident technique.

Being tested
Lidocaine-adrenaline added gadolinium.
Keywords
Hip surgery anesthesia, Perioperative analgesia
Medical subject headings
Hip Fractures, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lidocaine-adrenaline added gadolinium.Drug

Study groups in NCT02255591
Study groupRoleWhat they receive
ShamrockExperimentalUse of the Shamrock technique to place a lumbar plexus block with injection of 20 mL 2% Lidocaine-adrenaline added gadolinium.
Receives: Drug: Lidocaine-adrenaline added gadolinium.
Lumbar Ultrasound TridentActive comparatorUse of the Lumbar Ultrasound Trident technique to place a lumbar plexus block with injection of 20 mL 2% lidocaine-adrenaline added gadolinium.
Receives: Drug: Lidocaine-adrenaline added gadolinium.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Block performance time

    Time for performance of lumbar plexus block in seconds from placement of the ultrasound transducer on the skin until the block needle is pulled out after injection of local anesthetics.

    Measured: Estimated 0 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

Secondary outcomes (15)
  1. Number of needle feeds

    Needle feeds are defined as retraction of needle followed by new feed of the needle disregarding the number of skin punctures.

    Measured: Estimated 0 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  2. Discomfort during block placement

    Discomfort is measured with Numeric Rating Scale (NRS).

    Measured: Estimated 1 minute after block placement. Presented 10 months after the last visit of the last volunteer.

  3. Plasma Lidocaine

    Measured: Blood samples are withdrawn 0, 5, 10, 20, 40, 60, and 90 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  4. Mear arterial pressure

    Measured: Measured 5 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  5. Cost-effectiveness

    Cost-effectiveness estimated as extra expense per successful lumbar plexus block and calculated as incremental cost-effectiveness ratio (ICER).

    Measured: Calculated two weeks after the last visit of the last volunteer. Presented 10 months after the last visit of the last volunteer.

  6. Sensor block

    Sensor block (cold, warm, touch, and pain) of the dermatomes T8-S3 and of the femoral nerve and the lateral femoral cutaneous nerve.

    Measured: Tested 30 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  7. Motor block

    Motor block of the femoral nerve (knee extension), the obturator nerve (hip adduction), the superior gluteal nerve (hip abduction), and the sciatic nerve (knee flexion) estimated as active resistance against movement of the relevant joint and with sphygmomanometer of the relevant joint as maximal voluntary isometric contraction with dynamometer (mmHg).

    Measured: Tested 40 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  8. Block success rate

    Success rate defined as motor block of the femoral nerve (knee extension) and the obturator nerve (hip adduction) and reduced sensory of the lateral femoral cutaneous nerve (middle of the lateral side of the thigh).

    Measured: Tested 30 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  9. Block success rate

    Defined as above after lumbar plexus block with the Shamrock technique for motor response on electrical nerve stimulation above respectively below 0,5 milliampere (mA).

    Measured: Tested 30 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  10. Epidural spread of local anesthetics with contrast

    Estimated with T1- and T2-weighted and with diffusion weighted imaging (DWI) MR scanning.

    Measured: Estimated 10-30 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  11. Perineural spread of local anesthetics with added contrast

    Estimated with T1- and T2-weighted and with DWI MR scanning.

    Measured: Estimated 10-30 minutes after block placement. Presented 10 months after the last visit of the last volunteer.

  12. Depth of block needle

    The depth in cm from the injection site in the skin to the needle tips position during injection. of local anesthetics

    Measured: Estimated during block

  13. Injection site

    The distance in cm from the injection site of the block needle to the midline of the volunteer.

    Measured: Estimated immediately after block placement

  14. Minimal electrical nerve stimulation

    The estimated minimal electrical nerve stimulation in mA to trigger a muscular response.

    Measured: Estimated immediately before injection of local anesthetics during block placement

  15. Type of response on electrical nerve stimulation

    The type of response triggered by electrical nerve stimulation.

    Measured: Assessed immediately before injection of local anesthetics during block placement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2014 (estimated)
  2. Study startFeb 2015
  3. Primary completionMar 2015
  4. Study completionMar 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02255591
Sponsor's protocol ID
AUH-TFB-SR
Other IDs
2013-005346-10
Status last verified
Sep 2014
First submitted
22 Sep 2014
Last updated
1 May 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • de Visme V, Picart F, Le Jouan R, Legrand A, Savry C, Morin V. Combined lumbar and sacral plexus block compared with plain bupivacaine spinal anesthesia for hip fractures in the elderly. Reg Anesth Pain Med. 2000 Mar-Apr;25(2):158-62. doi: 10.1053/rapm.2000.0250158.

    PubMed 10746528
  • Kirchmair L, Entner T, Kapral S, Mitterschiffthaler G. Ultrasound guidance for the psoas compartment block: an imaging study. Anesth Analg. 2002 Mar;94(3):706-10; table of contents. doi: 10.1097/00000539-200203000-00042.

    PubMed 11867402
  • Kirchmair L, Entner T, Wissel J, Moriggl B, Kapral S, Mitterschiffthaler G. A study of the paravertebral anatomy for ultrasound-guided posterior lumbar plexus block. Anesth Analg. 2001 Aug;93(2):477-81, 4th contents page. doi: 10.1097/00000539-200108000-00047.

    PubMed 11473883
  • Morimoto M, Kim JT, Popovic J, Jain S, Bekker A. Ultrasound-guided lumbar plexus block for open reduction and internal fixation of hip fracture. Pain Pract. 2006 Jun;6(2):124-6. doi: 10.1111/j.1533-2500.2006.00074.x.

    PubMed 17309721
  • Doi K, Sakura S, Hara K. A modified posterior approach to lumbar plexus block using a transverse ultrasound image and an approach from the lateral border of the transducer. Anaesth Intensive Care. 2010 Jan;38(1):213-4. No abstract available.

    PubMed 20191806
  • Madison SJ, Ilfeld BM, Loland VJ, Mariano ER. Posterior lumbar plexus perineural catheter insertion by ultrasound guidance alone. Acta Anaesthesiol Scand. 2011 Sep;55(8):1031-2. doi: 10.1111/j.1399-6576.2011.02489.x. Epub 2011 Jul 20. No abstract available.

    PubMed 21770905
  • Karmakar MK, Ho AM, Li X, Kwok WH, Tsang K, Ngan Kee WD. Ultrasound-guided lumbar plexus block through the acoustic window of the lumbar ultrasound trident. Br J Anaesth. 2008 Apr;100(4):533-7. doi: 10.1093/bja/aen026.

    PubMed 18344573
  • Strid JMC, Sauter AR, Ullensvang K, Andersen MN, Daugaard M, Bendtsen MAF, Soballe K, Pedersen EM, Borglum J, Bendtsen TF. Ultrasound-guided lumbar plexus block in volunteers; a randomized controlled trial. Br J Anaesth. 2017 Mar 1;118(3):430-438. doi: 10.1093/bja/aew464.

    PubMed 28203808

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Lidocaine-adrenaline added gadolinium. in people with Hip Fractures and Anesthesia Local, run by University of Aarhus at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Block performance time (time frame: Estimated 0 minutes after block placement. Presented 10 months after the last visit of the last volunteer.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02255591, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in